The Food and Drug Administration (FDA) approved Merck’s immunotherapy Keytruda for early treatment of triple-negative breast cancer (TNBC) in combination with chemotherapy, the pharmaceutical company announced on Tuesday. The federal agency’s…
Copyright © 2024 | WordPress Theme by MH Themes